Enhancer ID: | E_01_0732 |
Species: | human |
Position : | chr17:49596074-49598074 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Non small cell lung cancer |
Pubmed ID: | 30190126 |
Enhancer experiment: | Statistical analysis, Weston blot, RT qPCR |
Enhancer experiment description: | Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. |
Target gene : | SPOP,FADD |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. ; Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. |
TF name : | -- |
TF experiment: | ????,weston blot,RT-qPCR |
TF experiment description: | Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. ; Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. |
Enhancer function : | Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Notably, SPOP inhibits NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity and its target genes expression via FADD. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|